These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32555111)

  • 21. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group.
    Malmstrom K; Rodriguez-Gomez G; Guerra J; Villaran C; Piñeiro A; Wei LX; Seidenberg BC; Reiss TF
    Ann Intern Med; 1999 Mar; 130(6):487-95. PubMed ID: 10075616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse events associated with weight-based, high-dose montelukast exposures in children.
    Arnold DH; Bowman N; Reiss TF; Hartert TV; Akers WS; Seger DL
    Clin Toxicol (Phila); 2020 Feb; 58(2):145-146. PubMed ID: 31056949
    [No Abstract]   [Full Text] [Related]  

  • 23. The efficacy and tolerability of intravenous montelukast in acute asthma exacerbations in Japanese patients.
    Adachi M; Taniguchi H; Tohda Y; Sano Y; Ishine T; Smugar SS; Hisada S
    J Asthma; 2012 Aug; 49(6):649-56. PubMed ID: 22742205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiasthmatic effects of mediator blockade versus topical corticosteroids in allergic rhinitis and asthma.
    Wilson AM; Orr LC; Sims EJ; Dempsey OJ; Lipworth BJ
    Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1297-301. PubMed ID: 11029334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Montelukast in the treatment of allergic rhinitis: an evidence-based review.
    Nayak A; Langdon RB
    Drugs; 2007; 67(6):887-901. PubMed ID: 17428106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, placebo-controlled study of intravenous montelukast in children with acute asthma.
    Morris CR; Becker AB; Piñieiro A; Massaad R; Green SA; Smugar SS; Gurner DM
    Ann Allergy Asthma Immunol; 2010 Feb; 104(2):161-71. PubMed ID: 20306820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary eosinophilia associated with montelukast.
    Franco J; Artés MJ
    Thorax; 1999 Jun; 54(6):558-60. PubMed ID: 10335014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent panniculitis in a man with asthma receiving treatment with leukotriene-modifying agents.
    Dellaripa PF; Wechsler ME; Roth ME; Drazen J
    Mayo Clin Proc; 2000 Jun; 75(6):643-5. PubMed ID: 10852428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Montelukast-induced hepatitis.
    Goldstein MF; Anoia J; Black M
    Ann Intern Med; 2004 Apr; 140(7):586-7. PubMed ID: 15069001
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
    Virchow JC; Bachert C
    Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Montelukast dose selection in children ages 2 to 5 years: comparison of population pharmacokinetics between children and adults.
    Knorr B; Nguyen HH; Kearns GL; Villaran C; Boza ML; Reiss TF; Rogers JD; Zhang J; Larson P; Spielberg S
    J Clin Pharmacol; 2001 Jun; 41(6):612-9. PubMed ID: 11402629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Montelukast-Induced Angioedema.
    Gill D; Mann K; Wani L
    Am J Ther; 2017; 24(5):e624-e625. PubMed ID: 27574946
    [No Abstract]   [Full Text] [Related]  

  • 33. Association between leukotriene-modifying agents and suicide: what is the evidence?
    Schumock GT; Lee TA; Joo MJ; Valuck RJ; Stayner LT; Gibbons RD
    Drug Saf; 2011 Jul; 34(7):533-44. PubMed ID: 21663330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Montelukast and Churg-Strauss syndrome.
    Hosker HS; Tuggey JM
    Thorax; 2001 Mar; 56(3):244. PubMed ID: 11245146
    [No Abstract]   [Full Text] [Related]  

  • 35. A randomized open-label comparative study of montelukast versus theophylline added to inhaled corticosteroid in asthmatic children.
    Kondo N; Katsunuma T; Odajima Y; Morikawa A
    Allergol Int; 2006 Sep; 55(3):287-93. PubMed ID: 17075269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutaneous lesions of Churg-Strauss syndrome associated with montelukast therapy.
    Gal AA; Morris RJ; Pine JR; Spraker MK
    Br J Dermatol; 2002 Sep; 147(3):618-9. PubMed ID: 12207620
    [No Abstract]   [Full Text] [Related]  

  • 37. Extrapolating evidence beyond age groups.
    Bisgaard H; Bønnelykke K
    J Allergy Clin Immunol; 2008 Apr; 121(4):1066-7; author reply 1067-8. PubMed ID: 18325574
    [No Abstract]   [Full Text] [Related]  

  • 38. Histological appearances of putative montelukast related Churg-Strauss syndrome.
    Currie GP; McKinlay L; Kerr KM
    Thorax; 2008 Dec; 63(12):1120. PubMed ID: 19020279
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effectiveness and safety of montelukast versus budesonide at various doses on bronchial reactivity in subjects with mild persistent asthma].
    Riccioni G; D'Orazio N; Di Ilio C; Della Vecchia R; De Lorenzo A
    Clin Ter; 2002; 153(5):317-21. PubMed ID: 12510415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Daily inhaled corticosteroids or montelukast for preschoolers with asthma or recurrent wheezing: A systematic review.
    Castro-Rodriguez JA; Rodriguez-Martinez CE; Ducharme FM
    Pediatr Pulmonol; 2018 Dec; 53(12):1670-1677. PubMed ID: 30394700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.